tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Steve Mcgarry, 2 are a HOLD (50%), 2 are a BUY (50%).
Analyst Steve Mcgarry, currently employed at HSBC, carries an average stock price target met ratio of 27.78% that have a potential upside of 11.78% achieved within 208 days.
Steve Mcgarry’s has documented 13 price targets and ratings displayed on 3 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on GSK, GlaxoSmithKline PLC ADR at 18-Feb-2022.
Analyst best performing recommendations are on GSK (GLAXOSMITHKLINE PLC ADR).
The best stock recommendation documented was for GSK (GLAXOSMITHKLINE PLC ADR) at 2/18/2022. The price target of $29.46 was fulfilled within 210 days with a profit of $10.9 (27.01%) receiving and performance score of 1.29.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
9 days ago
(15-Nov-2024)
0/13 (0%)
$-19.36 (-47.20%)
Buy
$39.5
$5.8 (17.21%)
$53
12 days ago
(12-Nov-2024)
2/5 (40%)
$4 (11.27%)
368
Buy
$22.07
4 months 16 days ago
(08-Jul-2024)
0/14 (0%)
$-16.41 (-42.65%)
Hold
$44
$10.3 (30.56%)
$18.72
10 months 1 days ago
(23-Jan-2024)
1/14 (7.14%)
$5.42 (14.05%)
107
Hold
$19.52
$-14.18 (-42.08%)
$18.9
1 years 3 months 10 days ago
(14-Aug-2023)
0/3 (0%)
$-14.59 (-42.77%)
What Year was the first public recommendation made by Steve Mcgarry?
